Is Big Pharma Ignoring a Potential Cancer Cure?
Small trials and case studies won't be enough, however, to prove DCA works. Further investigation into the drug's efficacy is necessary, and without the help of Big Pharma, it will have to happen in an unusual way.
Editor's Note: This story and headline were updated May 18 to remove any impression that Big Pharma is to blame for the lack of research into DCA. In fact, as the story stated, the lack of financial incentive (the inability to patent DCA) is what discourages drug companies from studying the chemicals.
Read more: http://www.foxnews.com/health/2011/05/18/big-pharma-ignoring-potential-cancer-cure/#ixzz2DJAjjAnU